Ezekiel Elliott says Patriots are a good fit after signing 1-year deal
Published Fri, 21 Feb 2025 18:04:21 GMT
Going Long: Boston has solution to opioid epidemic but it’s years away
Published Fri, 21 Feb 2025 18:04:21 GMT
Mercenary leader Yevgeny Prigozhin is presumed dead after a plane crash outside Moscow
Published Fri, 21 Feb 2025 18:04:21 GMT
Nicaraguan government bans Jesuit order and says all its property will be confiscated
Published Fri, 21 Feb 2025 18:04:21 GMT
What’s going on with Scooter Braun’s artist roster? Here’s what we know and what’s still speculation
Published Fri, 21 Feb 2025 18:04:21 GMT
Man convicted of killing Kristin Smart is attacked in prison and hospitalized in serious condition
Published Fri, 21 Feb 2025 18:04:21 GMT
North Korea says its 2nd attempt to launch a spy satellite has failed, vows 3rd try
Published Fri, 21 Feb 2025 18:04:21 GMT
At least 1 person is dead and 2 are missing as Tropical Storm Franklin batters Dominican Republic
Published Fri, 21 Feb 2025 18:04:21 GMT
18-year-old at large, teen charged after 15-year-old shot in Palatine dies, ID'd
Published Fri, 21 Feb 2025 18:04:21 GMT
Mug shots released in Trump Georgia election case
Published Fri, 21 Feb 2025 18:04:21 GMT
Latest news
- Patriots rookie Malik Cunningham has taken on another expected role on offense
- Mystery travel lets you focus on the fun, not the details
- US, Japan and South Korea open summit to bolster security over objections of Beijing
- Some issues remain as Kentucky school district restarts classes after busing fiasco
- Chess chiefs ask why it’s still mostly a man’s game. Culture, but hormones and endurance too?
- Shortage of diabetes and weight loss drug Ozempic expected in Canada: manufacturer
- Home prices post second-biggest monthly jump since 2006: Teranet
- Tilray takes full ownership of Truss Beverage from Molson Coors Canada
- What to stream this weekend: ‘Monkey King,’ Stand Up to Cancer, ‘No Hard Feelings,’ Madden NFL 24
- 3 of 5 former Memphis officers charged in Tyre Nichols’ death want separate trials